国际前列腺症状评分的汉化与评价
|
摘要
目的评价国际前列腺症状评分中文版本(IPSS-Ch)的性能。方法经过一系列翻译及修正最终完成IPSS-Ch版。选择74例良性前列腺增生(BPH)患者在入院时、入院3～5 d以及经尿道前列腺电切术(TURP)术后4周进行3次测试,选择45例对照组在返院领取体检报告时进行1次IPSS-Ch测试,比较分析IPSS-Ch评分量表的可行性、信度和效度。结果 BPH患者初次完成IPSS-Ch的平均时间为(7.12±2.35)min,其中59例(79.73%)在完成量表的过程中需要医务人员的协助。患者初次受试7个条目总分为(21.92±5.89)分,Cronbach’sα系数为0.83;BPH患者间隔3～5 d再次受试的重测信度为0.95,BPH患者第3次测试的前7个条目总分、各条目得分及生活质量的IPSS-Ch评分均低于第1次测试(t分别=14.14、6.06、7.80、8.62、10.57、11.85、8.95、10.95、17.87,P均<0.05)。对照组前7个条目总分、各条目得分及生活质量的IPSS-Ch评分均低于BPH患者的第1次测试(t分别=15.12、7.89、8.48、10.51、11.43、13.51、10.62、8.67、14.79,P均<0.05)。结论 IPSS-Ch具有良好的信度和效度,可被应用于临床和科研,但在现阶段老年人受教育水平较低的我国自助性欠佳。
Objective To validate the performance of a Chinese version of the international prostate symptom score(IPSS). Methods A Chinese version of the IPSS(IPSS-Ch)was developed through a series of steps of translation and modification.Feasibility,reliability and validity were studied between 74 patients with BPH who completed the IPSS-Ch on admission,3～5 d after admission,and 4 weeks after transurethral resection of prostate(TURP)and 45 control subjects without BPH who received IPSS-Ch on fetching the medical examination reports. Results The average time to complete the questionnaires at the first time in the BPH group was 7.12±2.35 minutes.Totally 59 patients(79.73%)called for assistance in the process of completing the form.The mean IPSS-Ch scores was 21.92±5.89,and the Cronbach'sα coefficient for the IPSS-Ch was 0.83.The test-retest reliability with a interval of 3～5 days was 0.95.The scores of the overall scale,each item and quality of life item of the BPH patients at the third time were significantly lower than those of the first test(t=14.14,6.06,7.80,8.62,10.57,11.85,8.95,10.95,17.87,P<0.05).The scores of the overall scale,each item and quality of life item of the control group were significantly lower than those of the BPH group at the first time(t=15.12,7.89,8.48,10.51,11.43,13.51,10.62,8.67,14.79,P<0.05). Conclusions IPSS-Ch is valid,reliable,and sensitive to clinical change.However,the feasibility is defective because of the low educaional level of the old men in China.
Objective To validate the performance of a Chinese version of the international prostate symptom score(IPSS). Methods A Chinese version of the IPSS(IPSS-Ch)was developed through a series of steps of translation and modification.Feasibility,reliability and validity were studied between 74 patients with BPH who completed the IPSS-Ch on admission,3～5 d after admission,and 4 weeks after transurethral resection of prostate(TURP)and 45 control subjects without BPH who received IPSS-Ch on fetching the medical examination reports. Results The average time to complete the questionnaires at the first time in the BPH group was 7.12±2.35 minutes.Totally 59 patients(79.73%)called for assistance in the process of completing the form.The mean IPSS-Ch scores was 21.92±5.89,and the Cronbach'sα coefficient for the IPSS-Ch was 0.83.The test-retest reliability with a interval of 3～5 days was 0.95.The scores of the overall scale,each item and quality of life item of the BPH patients at the third time were significantly lower than those of the first test(t=14.14,6.06,7.80,8.62,10.57,11.85,8.95,10.95,17.87,P<0.05).The scores of the overall scale,each item and quality of life item of the control group were significantly lower than those of the BPH group at the first time(t=15.12,7.89,8.48,10.51,11.43,13.51,10.62,8.67,14.79,P<0.05). Conclusions IPSS-Ch is valid,reliable,and sensitive to clinical change.However,the feasibility is defective because of the low educaional level of the old men in China.
引文
1 Committee APG.AUA guideline on management of benign prostatic hyperplasia(2003).chapter 1:diagnosis and treatment recommendations[J].J Urol,2003,170(2):530-547.
2项彬斌,罗鹰,苏钢锋.双极等离子前列腺电切治疗前列腺增生在基层医院中的应用体会[J].全科医学临床与教育,2018,16(3):316-317.
3 Barry MJ,Fowler FJ,O’Leary MP,et al.The American urological association symptom index for benign prostatic hyperplasia[J].J Urol,1992,148(5):1549-1557.
4 Okamura K,Nojiri Y,Osuga Y,et al.Psychometric analysis of international prostate symptom score for female lower urinary tract symptoms[J].Urology,2009,73(6):1199-1202.
5 Afriansyah A,Gani YI,Nusali H.Comparison between visual prostate symptom score and international prostate symptom score in males older than 40 years in rural Indonesia[J].Prostate Int,2014,2(4):176.
6 Ogwuche EI,Dakum NK,Amu CO,et al.Problems with administration of international prostate symptom score in a developing community[J].Ann Afr Med,2013,12(3):171-173.
7 Macdiarmid SA,Goodson TC,Holmes TM,et al.An assessment of the comprehension of the american urological association symptom index[J].J Urol,1998,159(3):873-874.
8 Van Walt CLE,Heyns CF,Groeneveld AE,et al.prospective comparison of a new visual prostate symptom score versus the international prostate symptom score in men with lower urinary tract symptoms[J].Urology,2011,78(1):17-20.
9 Abiola OO,Ajape AA,Adeniyi SO,et al.Use and ease of self-administered international prostate symptoms score(IPSS)and visual prostate symptoms score(VPSS)questionnaires for the assessment of lower urinary tract symptoms in Nigerian men[J].African J Urol,2016,22(2):121-126.
2项彬斌,罗鹰,苏钢锋.双极等离子前列腺电切治疗前列腺增生在基层医院中的应用体会[J].全科医学临床与教育,2018,16(3):316-317.
3 Barry MJ,Fowler FJ,O’Leary MP,et al.The American urological association symptom index for benign prostatic hyperplasia[J].J Urol,1992,148(5):1549-1557.
4 Okamura K,Nojiri Y,Osuga Y,et al.Psychometric analysis of international prostate symptom score for female lower urinary tract symptoms[J].Urology,2009,73(6):1199-1202.
5 Afriansyah A,Gani YI,Nusali H.Comparison between visual prostate symptom score and international prostate symptom score in males older than 40 years in rural Indonesia[J].Prostate Int,2014,2(4):176.
6 Ogwuche EI,Dakum NK,Amu CO,et al.Problems with administration of international prostate symptom score in a developing community[J].Ann Afr Med,2013,12(3):171-173.
7 Macdiarmid SA,Goodson TC,Holmes TM,et al.An assessment of the comprehension of the american urological association symptom index[J].J Urol,1998,159(3):873-874.
8 Van Walt CLE,Heyns CF,Groeneveld AE,et al.prospective comparison of a new visual prostate symptom score versus the international prostate symptom score in men with lower urinary tract symptoms[J].Urology,2011,78(1):17-20.
9 Abiola OO,Ajape AA,Adeniyi SO,et al.Use and ease of self-administered international prostate symptoms score(IPSS)and visual prostate symptoms score(VPSS)questionnaires for the assessment of lower urinary tract symptoms in Nigerian men[J].African J Urol,2016,22(2):121-126.